-transparent.png){kind=logo}
Twenty-six patients with metastatic pancreatic or gastric adenocarcinoma were treated with 5-fluorouracil, Adriamycin, and mitomycin C. One complete and five partial responses were observed among 15 patients with pancreatic adenocarcinoma (40% response rate) and six partial responses were observed among 11 patients with gastric adenocarcinoma (55% response rate). Responders had a significantly longer survival than nonresponders in both groups.
Related Publications
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
January 1982,
Cancer chemotherapy and pharmacology,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
July 1979,
Cancer,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
January 1986,
Cancer,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
July 1982,
Cancer,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
April 1979,
Cancer,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
May 1984,
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
November 1984,
Cancer,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
October 1986,
American journal of clinical oncology,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
January 1988,
Israel journal of medical sciences,
J D Bitran, and
R K Desser, and
M F Kozloff, and
A A Billings, and
C M Shapiro
November 1980,
Cancer,
